PNEUMOCOCCAL CONJUGATE VACCINE
Drug
SANOFI PASTEUR INC.
Total Payments
$389,823
Transactions
11
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $389,823 | 11 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $389,823 | 11 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults 19 to 49 years | SANOFI PASTEUR INC. | $389,823 | 0 |
Top Doctors Receiving Payments for PNEUMOCOCCAL CONJUGATE VACCINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Metairie, LA | $389,823 | 11 |
Ad
Manufacturing Companies
- SANOFI PASTEUR INC. $389,823
Product Information
- Type Drug
- Total Payments $389,823
- Total Doctors 0
- Transactions 11
About PNEUMOCOCCAL CONJUGATE VACCINE
PNEUMOCOCCAL CONJUGATE VACCINE is a drug associated with $389,823 in payments to 0 healthcare providers, recorded across 11 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI PASTEUR INC..
Payment data is available from 2019 to 2019. In 2019, $389,823 was paid across 11 transactions to 0 doctors.
The most common payment nature for PNEUMOCOCCAL CONJUGATE VACCINE is "Unspecified" ($389,823, 100.0% of total).
PNEUMOCOCCAL CONJUGATE VACCINE is associated with 1 research study, including "Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults 19 to 49 years" ($389,823).